RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: Viral Bronchiolitis
Accession: DOID:9006928
browse the term
Definition: An acute inflammatory disease of the lower RESPIRATORY TRACT, caused by paramyxoviruses, occurring primarily in infants and young children; the viruses most commonly implicated are PARAINFLUENZA VIRUS TYPE 3; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; and METAPNEUMOVIRUS.
Synonyms: exact_synonym: Viral Bronchiolitides
primary_id: MESH:D001990
For additional species annotation, visit the
Alliance of Genome Resources .
G
ADAM33
ADAM metallopeptidase domain 33
susceptibility
ISO
DNA:SNP: :rs2787094 c.2891G>C (human)
RGD
PMID:19258923
RGD:4142862
NCBI chr20:3,750,158...3,764,262
Ensembl chr20:3,508,620...3,521,628
G
BCL2
BCL2 apoptosis regulator
severity
ISO
protein:increased expression:natural killer cell, T cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr18:56,481,212...56,679,012
Ensembl chr18:59,802,443...59,992,100
G
BCL2L1
BCL2 like 1
severity
ISO
protein:increased expression:natural killer cell,t cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr20:27,955,688...28,015,950
Ensembl chr20:29,088,055...29,146,585
G
C3
complement C3
resistance
ISO
RGD
PMID:12235218 PMID:19258923
RGD:4142862 RGD:5129513
NCBI chr19:5,708,211...5,753,178
Ensembl chr19:6,629,287...6,674,699
G
CASP1
caspase 1
ISO
RGD
PMID:15196254
RGD:5130189
NCBI chr11:99,965,964...99,975,640
Ensembl chr11:103,448,497...103,458,149 Ensembl chr11:103,448,497...103,458,149
G
CAT
catalase
ISO
protein:decreased expression:lung protein:decreased expression:nasal mucus
RGD
PMID:21471094
RGD:5130770
NCBI chr11:34,413,253...34,446,831
Ensembl chr11:34,289,603...34,323,160
G
CCL5
C-C motif chemokine ligand 5
susceptibility
ISO
protein:increased secretion:serum (human) DNA:snp:5' utr:g.-28C>G (human)
RGD
PMID:19005677 PMID:19099677
RGD:4891881 RGD:4891884
NCBI chr17:20,915,198...20,923,530
Ensembl chr17:21,210,798...21,219,172
G
CD14
CD14 molecule
ISO
DNA:polymorphism:promoter:c.-550C>T (human)
RGD
PMID:17471431
RGD:4144210
NCBI chr 5:135,996,265...135,997,909
Ensembl chr 5:142,113,082...142,118,966
G
CD274
CD274 molecule
treatment
ISO
mRNA:increased expression:lung
RGD
PMID:22797302
RGD:40818270
NCBI chr 9:5,269,270...5,289,629
Ensembl chr 9:5,454,391...5,474,402
G
CSF2
colony stimulating factor 2
ISO
protein:increased expression:nasal mucus
RGD
PMID:20088864
RGD:4143440
NCBI chr 5:127,496,951...127,499,325
Ensembl chr 5:133,660,775...133,663,146
G
CX3CR1
C-X3-C motif chemokine receptor 1
ISO
DNA:SNP: :p.T280M (human)
RGD
PMID:16645504 PMID:18257903
RGD:4891891 RGD:4891905
NCBI chr 3:39,158,346...39,176,604
Ensembl chr 3:39,440,955...39,457,219
G
CXCL10
C-X-C motif chemokine ligand 10
ISO
mRNA:increased expression:lung protein:increased expression:plasma
RGD
PMID:12909590 PMID:20561238
RGD:2311388 RGD:5135493
NCBI chr 4:48,182,355...48,184,733
Ensembl chr 4:54,020,204...54,022,606
G
CXCR3
C-X-C motif chemokine receptor 3
ISO
RGD
PMID:20561238
RGD:5135493
NCBI chr X:60,880,759...60,883,355
Ensembl chr X:70,933,160...70,935,756
G
FAS
Fas cell surface death receptor
severity
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr10:85,707,457...85,741,539
Ensembl chr10:89,217,949...89,243,612
G
FLT3
fms related receptor tyrosine kinase 3
severity
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr13:9,283,747...9,381,553
Ensembl chr13:27,627,178...27,723,940
G
GAPDH
glyceraldehyde-3-phosphate dehydrogenase
severity
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr12:6,665,218...6,669,170
Ensembl chr12:6,583,895...6,587,729
G
IL15
interleukin 15
severity
ISO
mRNA,protein:increased expression:peripheral blood mononuclear cell,serum,dendritic cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr 4:133,693,995...134,115,470
Ensembl chr 4:145,402,111...145,416,622
G
IL17A
interleukin 17A
susceptibility
ISO
DNA:SNP: :rs7747909(human)
RGD
PMID:17703412
RGD:4889847
NCBI chr 6:51,736,269...51,740,538
Ensembl chr 6:53,004,820...53,009,074
G
IL33
interleukin 33
ISO
protein:increased expression:nasal mucus
RGD
PMID:28471975
RGD:38596342
NCBI chr 9:6,027,014...6,069,540
Ensembl chr 9:6,234,178...6,248,624
G
IL4R
interleukin 4 receptor
susceptibility
ISO
associated with respiratory syncystial virus infection; DNA:polymorphism:cds:p. Q551R (human) DNA:SNPs: :rs1805011,rs2057768 (human)
RGD
PMID:12508140 PMID:17703412 PMID:20404812
RGD:4889847 RGD:4889996 RGD:4890022
Ensembl chr16:27,642,702...27,737,445
G
IL6
interleukin 6
ISO
mRNA, protein:increased expression:respiratory system fluid/secretion
RGD
PMID:14738241
RGD:5128668
NCBI chr 7:23,415,922...23,420,767
G
IL9
interleukin 9
ISO
RGD
PMID:15051283
RGD:5128692
NCBI chr 5:131,283,170...131,289,777
Ensembl chr 5:137,425,367...137,428,945
G
JAK3
Janus kinase 3
severity
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr19:17,299,129...17,330,700
Ensembl chr19:18,283,560...18,300,964
G
KLRK1
killer cell lectin like receptor K1
susceptibility
ISO
DNA:SNP,haplotypes:3'utr: (rs10772271) (human)
RGD
PMID:29967528
RGD:39128159
NCBI chr12:10,411,932...10,429,256
Ensembl chr12:10,662,424...10,699,078
G
LOC100976419
interferon lambda-1
exacerbates
ISO
associated with respiratory syncytial virus infectious disease;mRNA:increased expression:mucosa of nasopharynx (human)
RGD
PMID:24389019
RGD:126848743
NCBI chr19:36,394,462...36,397,363
Ensembl chr19:44,942,186...44,944,519
G
LOC100988550
signal transducer and activator of transcription 5A
severity
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr17:15,005,025...15,029,110
Ensembl chr17:15,228,465...15,251,783
G
LOC100991079
interleukin-1 receptor antagonist protein
susceptibility
ISO
DNA:SNP: :c.390T>C (rs315952) (human)
RGD
PMID:19258923
RGD:4142862
NCBI chr2A:88,991,646...89,008,013
Ensembl chr2A:114,061,182...114,078,839
G
MPO
myeloperoxidase
ISO
RGD
PMID:7841728
RGD:5130995
NCBI chr17:52,333,882...52,357,838
Ensembl chr17:57,201,073...57,212,111
G
MUC1
mucin 1, cell surface associated
severity
ISO
protein:increased expression:serum
RGD
PMID:19856476
RGD:5131164
NCBI chr 1:130,533,508...130,537,866
Ensembl chr 1:134,141,969...134,145,850
G
NFKB1
nuclear factor kappa B subunit 1
severity
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr 4:94,925,048...95,040,849
Ensembl chr 4:105,589,062...105,704,098
G
NFKBIA
NFKB inhibitor alpha
susceptibility
ISO
associated with respiratory syncytial virus infectious disease;DNA:SNP:promoter: (rs2233406) (human)
RGD
PMID:23487427
RGD:40902982
NCBI chr14:16,155,331...16,158,588
G
NOS2
nitric oxide synthase 2
susceptibility
ISO
DNA:SNP: :rs1060826(human)
RGD
PMID:17703412
RGD:4889847
NCBI chr17:28,984,295...29,021,516
Ensembl chr17:29,471,510...29,617,093
G
PDCD1
programmed cell death 1
ISO
protein:increased expression:CD8 T cell
RGD
PMID:22797302
RGD:40818270
NCBI chr2B:129,111,509...129,121,127
G
POSTN
periostin
ISO
mRNA,protein:increased expression:nasal mucus
RGD
PMID:28471975
RGD:38596342
NCBI chr13:18,779,297...18,815,207
Ensembl chr13:37,368,030...37,407,212
G
TLR4
toll like receptor 4
ISO
protein:decreased expression:neutrophil protein:increased expression:monocyte
RGD
PMID:14738455 PMID:19497921
RGD:4144183 RGD:4144819
NCBI chr 9:88,827,495...88,840,458
Ensembl chr 9:117,180,550...117,190,711
G
TLR5
toll like receptor 5
susceptibility
ISO
DNA:snp:cds:p.F616L rs5744174 (human)
RGD
PMID:19258923
RGD:4142862
NCBI chr 1:198,787,046...198,819,537
Ensembl chr 1:203,798,767...203,801,343
G
TNF
tumor necrosis factor
susceptibility
ISO
DNA:SNP: :rs1799724(human) DNA:polymorphism:promoter: c. -308A>G (human) protein:increased expression:nasal lavage fluid
RGD
PMID:17703412 PMID:19849941 PMID:20088864
RGD:4143440 RGD:4143441 RGD:4889847
NCBI chr 6:31,236,650...31,239,423
Ensembl chr 6:32,126,618...32,129,381
G
TNFRSF10A
TNF receptor superfamily member 10a
severity
ISO
mRNA:increased expression:peripheral blood mononuclear cell (human)
RGD
PMID:26541527
RGD:40902860
NCBI chr 8:22,440,502...22,476,790
Ensembl chr 8:19,378,547...19,414,724
G
TSLP
thymic stromal lymphopoietin
severity
ISO
mRNA, protein:increased expression:nasal mucus (human)
RGD
PMID:28471975
RGD:38596342
NCBI chr 5:106,440,136...106,446,849
Ensembl chr 5:112,242,490...112,250,130
G
VDR
vitamin D receptor
susceptibility
ISO
DNA:SNP: :rs10735810 (human) DNA:SNP (human)
RGD
PMID:17703412 PMID:18266602
RGD:4889843 RGD:4889847
NCBI chr12:40,828,413...40,891,700
Ensembl chr12:41,702,742...41,766,192
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all